Antibody Companies in BioPortfolio's Corporate Database
Antibody company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest Antibody companies that have been added to our BioPortfolio's life-science corporate directory.
Search For More Antibody Companies
If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More Antibody Companies.
More Information about Antibody on BioPortfolio
We have published hundreds of Antibody news stories on BioPortfolio along with dozens of Antibody Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about Antibody for you to read.
Showing "antibody antibodies immunoglobulin" Companies 1 to 25 of 693
Acorda Therapeutics, Inc. was established in March 1995 to develop therapeutic products for spinal cord injury ("SCI") and other central nervous system disorders. Acorda is focusing its initial development efforts on a range of therapeutics for individuals with chronic, or long term, SCI. Currently, there is no therapy that improves neurological function in chronic SCI patients.However, Acorda's c...
Source BioScience LifeSciences
Source BioScience LifeSciences are European leaders in DNA sequencing, genomic services, bioinformatic analyses and offers a comprehensive portfolio of genomic reagents and antibodies. Source BioScience LifeSciences is your ideal outsourcing partner for all your sequencing requirements. We are your local Sanger sequencing provider operating facilities in London, Cambridge, Oxford, Nottingham,...
OncoMed Pharmaceuticals is a clinical-stage company that discovers and develops novel therapeutics targeting cancer stem cells, the cells believed to be capable of driving tumor growth, recurrence and metastases. A leader in cancer stem cell research, the company has established a library of antibodies to cancer stem cell proteins for the treatment of solid tumors such as pancreatic, breast, colo...
Onconova, based in Newtown, PA and Lawrenceville, NJ, discovers and develops novel patent- protected small molecule therapeutic agents for cancer, radiation protection and hematological disorders. The proprietary chemical library platform has yielded non-ATP competitive kinase inhibitors directed at validated and novel targets, and a new immunoconjugate te...
Seattle Genetics is a clinical-stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. The company's lead product candidate, brentuximab vedotin (SGN-35), is in a pivotal trial under a Special Protocol Assessment with the U.S. Food and Drug Admin...
Opsona is a leading immunology drug development company, focused on novel therapeutic approaches to key targets of the innate immune system associated with a wide range of major human diseases, including autoimmune and inflammatory diseases, solid organ transplantation, cancer, diabetes, Alzheimer's disease and others. The company was founded in 2004 by...
Virus Detection & Diagnostics Virinova
Our unique and proprietory diagnostic technology enables the detection and quantification of viruses without the use of PCR or antibodies - Direct detection of viruses and viral particles - Fast and simple - Suitable for known and unknown viruses Areas of application:Diagnosis and monitoring of viral infections - Known and unknown virusesProcess control in biotechnology - No...
In the biotechnology industry where the creation of any start-up depends on the input of the investors and on the fluctuations of the stock market, Covalab stands out as an exception. Indeed, with a minimum of initial capital and the assistance of University Claude Bernard (Lyon), the company developed slowly using as its foundation its know-how in Immunochemistry. The principal aim of its...
About Orla Orla Protein Technologies Ltd is a privately owned company based in Newcastle, UK. Its key assets are its protein and biosurface expertise, including protein design and manufacture, for biosurface applications. The company has a range of patented, fully-owned technologies that are used to provide bespoke solutions in these fields. Orla also has a joint-venture company, OJ Bio, in p...
Itero Biopharmaceuticals, Inc.
Itero Biopharmaceuticals, Inc. is a specialty biopharmaceutical company focused on the development and commercialization of protein therapeutics that offer significant clinical and commercial advantages over currently marketed alternatives. Itero is led by an executive team with 100+ collective years of successful experience in the development, manufacturi...
CytomX Therapeutics is an early stage biotechnology company developing Probodiesâ¢, or proteolytically-activated antibodies. Probodies combine the well-established power and specificity of monoclonal antibodies with a second level of tissue selectivity, driven by the action of endogenous disease enzymes. Probodies, by their ability to site-direct the activity...
DecImmune Therapeutics was founded by Michael Carroll PhD (The Immune Disease Institute, Harvard Medical School), and Francis Moore Jr. MD (Brigham and Womenâs Hospital, Harvard Medical School). Drs. Moore and Carroll discovered the epitope of non-muscle myocin heavy chain II (âN2â) that becomes exposed on vascular cells during hypoxia. During...
Rockland Immunochemicals has supported the biopharma and diagnostic industries for over 40 years with antibodies and antibody based toolsâ¢Â for basic research, assay development, and preclinical studies. With manufacturing facilities in Pennsylvania, Rockland produces over 10000 products designed for western blotting, immunohistochemistry (IHC), imm...
One Lambda Inc. is a world leader in the manufacture of HLA medical diagnostic products based in Canoga Park, California. The company is committed to develop products that improve the quality of life for transplant patients. Known for its dedication to quality, service and innovation since 1984, One Lambda develops and distributes several lines of HLA typi...
Hycult Biotech is a leader in the fields of immunology and cell biology, we develop, produce and market antibodies, antibody based products and more specifically immunoassays for innate immunity and directly related fields, with an emphasis on complement, neutrophil proteins, TLR, scavenger receptors and acute phase proteins. Furthermore, we have a strong...
Virdante Pharmaceuticals is developing safer and more effective drugs for autoimmune and inflammatory diseases. Our products incorporate a proprietary âSialic Switchâ technology to improve the anti-inflammatory properties of therapeutic antibodies. Virdante is applying this technology to develop novel therapeutics optimized for greater anti-infla...
Ironwood Pharmaceuticals, Inc. & Protagonist Therapeutics, Inc.
Protagonist Therapeutics is a privately held biotechnology company pursuing the discovery and development of disulfide rich peptides (DRPs) as well differentiated alternatives to antibodies and also as new chemical entities (NCEs) against those targets and diseases for which suitable small molecule and/or biologic options are either not ideal or not...
Santarus, Inc. and Pharming Group NV
Pharming Group NV is developing innovative products for the treatment of unmet medical needs. RUCONEST⢠(RHUCIN® in non-European territories) is a recombinant human C1 inhibitor approved for the treatment of angioedema attacks in patients with HAE in all 27 EU countries plus Norway, Iceland and Liechtenstein. The product is also under development f...
Arsanis is committed to the development of monoclonal antibody therapeutics against severe infectious diseases that cannot be controlled with currently available medical treatments. The Companyâs major focus is on life threatening infections that: are caused by antibiotic resistant pathogens; occur in immune compromised patients; or are associated wit...
BioLegend develops and manufactures world-class, cutting-edge antibodies and reagents at an outstanding value to customers for biomedical research. The broad product portfolio includes flow cytometry, cell biology, and functional reagents for research in immunology, cancer research, stem cells, and more. The aggressive product development program is accomp...
PolyTherics is a private UK biotech company that provides technology solutions to enable the development of better biopharmaceuticals. PolyTherics has developed proprietary technologies for the site-specific conjugation of polymers, such as polyethylene glycol (PEG), to any therapeutic peptide or protein, including antibodies, antibody fragments and protei...
Permeon Biologics is pioneering a breakthrough class of intracellular biologics that target a broad spectrum of previously undruggable targets. Leveraging its novel Intraphilin⢠Technology Platform, which has been exclusively licensed from Harvard University, the companyâs next-generation approach is being developed to unlock the full therapeutic...
ATLAB Pharma SAS is a French biotechnology company based in Nantes. ATLAB is developing a pipeline of targeted anti-cancer drugs including antibodies, Lutetium-177 beta-emitting radiopharmaceuticals, and astatine-211 alpha-emitting radiopharmaceuticals.
Conditas Biotechnology Group, LLC
Conditas Biotechnology Group, LLC is a boutique firm representing on- and off-shore Contract Research Organizations (CROs) and service providers in the biotechnology and pharmaceutical industry to their current and potential future customers from academia, biotech, and pharma. Based in Brookline, Massachusetts, their client CROs include experts in all...
Compugen is a leading therapeutic product discovery company focused on therapeutic proteins and monoclonal antibodies to address important unmet needs in the fields of immunology and oncology, either for Compugen or its partners. Unlike traditional high throughput trial and error experimental based drug candidate discovery, Compugen's discovery efforts are...
